BEN HIRSCHLER
AstraZeneca sells ageing beta-blocker to Recordati for $300 mlnAstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...- Brain damage in former players fuels soccer 'heading' fearsHEALTH-DEMENTIA-SOCCER:Brain damage in former players fuels soccer 'heading' fears
- RPT-Brain damage in former players fuels soccer 'heading' fearsHEALTH-DEMENTIA/SOCCER (REPEAT):RPT-Brain damage in former players fuels soccer 'heading' fears
- RPT-Brain damage in former players fuels soccer 'heading' fearsHEALTH-DEMENTIA/SOCCER (REPEAT):RPT-Brain damage in former players fuels soccer 'heading' fears
- Brain damage in former players fuels soccer 'heading' fearsHEALTH-DEMENTIA-SOCCER:Brain damage in former players fuels soccer 'heading' fears
Load More- RPT-Brain damage in former players fuels soccer 'heading' fears